Biotech

All Articles

Kairos goes public with $6M IPO to finance tests of cancer medication

.Along with a trio of biotechs reaching the Nasdaq on Friday, it was actually effortless to miss out...

Vaccine as well as Keytruda combo reliable in squamous tissue carcinoma

.Immune system gate inhibitors are actually the superheroes of cancer treatment. Medicines like Bris...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of significant management hirings, firings as we...

Regeneron's Opdualag competitor reveals 57% action price

.Regeneron is back along with long-term consequence for its own LAG-3 inhibitor and PD-1 prevention ...

AstraZeneca messages records on in-house opponents to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed an early look at the functionality of its internal antibody-drug...

iTeos- GSK's TIGIT superstar shows significant improvement

.After revealing a phase 3 launch based upon favorable midstage results, iTeos and also GSK are fina...

More joint FDA can easily accelerate rare illness R&ampD: report

.The FDA needs to be actually extra open and joint to let loose a rise in commendations of unusual h...

Zenas, MBX, Bicara scalp to Nasdaq in hot day for biotech IPOs

.It's an uncommonly busy Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Rehabs...

Atea's COVID antiviral falls short to halt hospital stays in period 3

.Atea Pharmaceuticals' antiviral has actually failed an additional COVID-19 trial, yet the biotech s...

Neurocrine's bid to save schizophrenia prospect stops working

.Neurocrine Biosciences' mental illness program pivot has failed. The biotech was actually incapable...